The Book Healing In Order

Creatine, Gut Inflammation, and the Brain: What New Research Reveals

An experimental study suggests that creatine may help protect brain cells during chronic intestinal inflammation. The findings reveal a surprising connection between the gut, the brain, and cellular energy.

Introduction: When Gut Inflammation Reaches Beyond the Gut

When we think about intestinal inflammation, we usually think about digestive symptoms.

Abdominal pain, diarrhea, bloating, and changes in bowel habits often receive the most attention.

But some people living with inflammatory bowel disease also experience problems that seem unrelated to digestion.

They may struggle with memory, concentration, fatigue, or mood changes.

Why might a disease affecting the intestines also affect the brain?

Researchers have been investigating this question through the gut–brain axis, the communication network connecting the digestive system, immune system, and brain.

A 2026 study published in Brain, Behavior, and Immunity examined this connection from an interesting perspective.

Scientists investigated whether creatine, a compound best known for supporting muscle energy, could protect brain cells during chronic intestinal inflammation.

The results were promising. However, the research was conducted in rats, not humans, and it does not establish creatine as a treatment for brain fog or inflammatory bowel disease.

What the Research Found About Creatine and Brain Inflammation

Researchers at Spanish universities induced chronic intestinal inflammation in male and female rats.

They then examined the hippocampus, a brain region involved in learning and memory.

Some animals received creatine monohydrate before and during the inflammatory challenge. Others did not.

The researchers measured inflammation, brain creatine levels, nerve-cell structure, and how nerve cells responded to electrical stimulation.

Three findings stood out.

1. Chronic intestinal inflammation was linked to changes in the brain.

Rats with colitis developed increased inflammatory activity in the hippocampus.

The researchers also observed changes in microglia, the brain’s resident immune cells.

Microglia normally help protect and maintain brain tissue. During chronic inflammation, their activity can change.

Male rats developed more pronounced changes in nerve-cell structure and electrical function than females.

This demonstrates an important feature of the experimental model: inflammation beginning in the intestines was accompanied by measurable changes in brain tissue.

2. Chronic colitis reduced creatine availability in the brain.

Creatine helps cells maintain a rapidly available supply of energy.

Although we often associate creatine with skeletal muscle, brain cells also use it.

In this study, chronic colitis reduced creatine concentrations in the hippocampus of both male and female rats.

Supplementation restored those concentrations toward normal values.

This suggests that intestinal inflammation may influence an energy-supporting compound in tissue far from the original inflammatory site.

However, the researchers did not directly measure whether mitochondrial energy production improved.

3. Creatine helped preserve brain-cell structure and electrical function.

In male rats with colitis, certain nerve cells became less responsive to electrical stimulation.

They required a stronger signal to generate an electrical impulse.

Researchers also detected changes in proteins associated with healthy nerve-cell structure.

Creatine supplementation prevented several of these abnormalities.

It also reduced inflammatory markers in the hippocampus of both sexes.

These findings are important because they go beyond showing a change in inflammation alone. They suggest preservation of certain physical and functional characteristics of brain cells.

Still, the study did not demonstrate improved memory, attention, or brain fog in humans.

Why the Gut–Brain Connection Matters in Real Life

Imagine someone living with chronic intestinal inflammation.

Their digestive symptoms are the most obvious problem. Yet they also report feeling mentally slower, more fatigued, or less able to concentrate.

It can be tempting to assume these experiences are unrelated.

But the body does not operate as a collection of isolated organs.

The intestines communicate with the brain through immune signals, nerves, hormones, and other biological pathways.

When inflammation persists, some of these signals may change.

That does not mean gut inflammation explains every cognitive symptom.

Poor sleep, anemia, nutritional deficiencies, medications, and many other conditions can contribute.

However, the study offers another example of why looking beyond the most obvious symptom matters.

It also raises a new question: can supporting vulnerable cells’ energy needs change how they respond to inflammation?

In this rat experiment, creatine was associated with measurable protection.

Whether similar benefits occur in people remains unknown.

How Creatine May Help Cells Respond to Stress

Creatine is a naturally occurring compound the body produces, and it comes from foods such as meat and fish.

Its best-known function involves helping cells maintain energy availability.

Cells use a molecule called ATP to perform work. Creatine and phosphocreatine help replenish ATP during periods of increased demand.

Think of this system as a small, rapidly accessible energy reserve.

Brain cells need a steady energy supply to maintain their electrical activity and communicate properly.

When inflammatory stress disrupts cellular function, that energy-supporting system may become particularly important.

Creatine may also influence inflammatory responses.

However, the new study cannot tell us exactly which action produced the protective findings.

There is another important complication.

Earlier research by the same investigators found that creatine also improved intestinal inflammation and barrier function in their animal model.

Therefore, the brain benefits may have resulted partly from reducing the original intestinal disturbance.

They may also have involved direct effects within the brain.

The researchers could not determine how much protection came from each pathway.

That distinction matters because protecting brain tissue while reducing gut inflammation is not the same as demonstrating brain protection independent of the gut.

How This Fits Into Healing in Order

A central principle of Healing in Order is that symptoms in one part of the body may reflect instability in another.

The Ettinger Foundation Protocol (EFP) organizes recovery around identifying and addressing the earliest unstable regulatory system.

Rather than treating every symptom as an independent problem, EFP asks which conditions must become stable before later demands can be increased.

The creatine study offers an experimental example of why this perspective matters.

The original disturbance was intestinal inflammation. Yet measurable changes appeared in the brain.

Creatine supplementation was associated with protection across several brain measurements.

This suggests that the consequences of inflammation can extend beyond the original tissue.

It does not prove that EFP’s sequence improves outcomes, nor does it establish creatine as an EFP treatment for these conditions.

Instead, the study reinforces an existing principle:

An unstable biological environment can place additional demands on other systems, even when those systems are not the original source of illness.

Phase Relevance: Immune–Gut Stability and Cellular Energy

Primary EFP Phase: Phase 2 — Immune–Gut Stability

Phase 2 concerns the stability of immune and digestive processes.

This study belongs primarily in Phase 2 because chronic intestinal inflammation was the initiating experimental disturbance.

The investigators examined how that inflammation affected brain tissue and how creatine changed the response.

Secondary EFP Phase: Phase 4 — Mitochondrial Adaptation / Energy

Creatine’s role in maintaining cellular energy availability gives the research a secondary connection to Phase 4.

However, the study did not measure mitochondrial respiration, exercise adaptation, recovery from exertion, or the ability to repeat physical demands.

Therefore, it should not be viewed as direct evidence for Phase 4 readiness.

The broader lesson is that inflammatory regulation and cellular energy systems interact, although this experiment did not establish the complete mechanism.

What This Research Changes

EFP Integration Status: Existing EFP Concept Strongly Strengthened — No Change Required.

The study adds useful experimental evidence connecting intestinal inflammation with changes in brain tissue and creatine availability.

It also supports further investigation of creatine as a possible protective compound in inflammatory conditions.

However, the findings do not justify changing EFP treatment sequencing or adding creatine to a Phase 2 clinical protocol.

The study used a high experimental dose in rats, with supplementation beginning before the inflammatory challenge.

There is no established human dose from this experiment for preventing brain inflammation or treating cognitive symptoms associated with inflammatory bowel disease.

The existing EFP hierarchy remains unchanged.

Clinical Pearls: What the Science Helps Us Understand

• Creatine is not only a muscle compound. The brain also uses creatine to help maintain cellular energy.
• Gut inflammation can affect tissues beyond the intestines. Animal research demonstrates measurable changes in brain tissue during chronic colitis.
• Brain immune cells respond to inflammation. Microglia help protect the brain, but their activity can change during prolonged inflammatory stress.
• Inflammation may affect how nerve cells function. The study detected changes in electrical signaling, not just inflammatory markers.
• A change in brain-cell function does not automatically mean memory loss. Cognitive outcomes require separate testing.
• Creatine restored reduced brain creatine levels in this model. That does not prove mitochondrial energy production improved.
• The original inflammatory condition still matters. Brain protection may have resulted partly from improved intestinal inflammation.
• Animal results are not proof of human treatment benefits. The study does not establish creatine as a therapy for brain fog or inflammatory bowel disease.
• The ability to tolerate an intervention is individual. A promising nutrient does not override the need to consider current physiological stability.

Practical Meaning for the Reader

If you live with intestinal inflammation and also experience cognitive difficulties, those symptoms deserve attention.

They should not automatically be dismissed as unrelated, nor should they automatically be attributed to gut inflammation.

A complete evaluation may uncover several contributing factors.

For people already taking creatine, this research provides an interesting reason scientists are studying its effects beyond muscle performance.

However, it is not a reason to increase a dose or begin supplementation specifically to treat brain inflammation.

The most useful message is that the gut, immune system, and brain influence one another.

Understanding those relationships may eventually lead to better ways of protecting neurological function during chronic illness.

Final Perspective: The Body Does Not Heal in Separate Compartments

We often describe illness by the organ where symptoms appear.

Digestive problems belong to the gut. Memory problems belong to the brain. Fatigue belongs to energy metabolism.

But biology is more connected than those categories suggest.

This study demonstrates that chronic intestinal inflammation can be accompanied by measurable changes in brain cells—and that creatine can prevent several of those changes in an experimental model.

The research does not prove that creatine treats human neurological symptoms.

It does reinforce a broader idea central to Healing in Order.

The condition of one biological system can influence how another system functions.

Understanding those relationships may help us ask better questions about chronic illness, even before we have all the answers.

Research Source

Ruiz-Calero A, Ortego-Domínguez M, Vázquez-Carretero MD, et al. Modulating effects of creatine prevent sex-dependent hippocampal neuroinflammation, neuronal damage, and electrophysiological dysfunction induced by chronic colitis. Brain, Behavior, and Immunity. 2026;138:106929.

DOI: 10.1016/j.bbi.2026.106929

This was a controlled animal experiment, not a human clinical trial. It does not establish creatine as a proven treatment for brain fog, cognitive impairment, or inflammatory bowel disease.